What is *Ending Aging* by Aubrey de Grey about?

*Ending Aging* outlines a scientific roadmap to reverse human aging by repairing seven types of cellular and molecular damage, such as mitochondrial mutations and extracellular matrix stiffening. Aubrey de Grey and Michael Rae argue that aging is a curable engineering problem, proposing therapies like stem cell regeneration and advanced detoxification to achieve "longevity escape velocity" and potentially indefinite lifespans.

Who should read *Ending Aging*?

This book is ideal for readers interested in biotechnology, longevity science, or radical healthspan extension. Scientists, futurists, and those curious about Aubrey de Grey’s SENS Research Foundation will find its technical yet accessible breakdown of aging mechanisms compelling, though critics note its speculative optimism.

Is *Ending Aging* worth reading?

Yes, for its provocative vision of defeating aging as a solvable problem. While some strategies remain unproven, the book’s framework for categorizing aging damage (e.g., protein cross-linking, cellular senescence) has influenced research directions. However, its 2007 publication date means newer advancements aren’t covered.

What are the seven types of aging damage identified in *Ending Aging*?

De Grey categorizes aging into: - Cell loss/atrophy - Nuclear mutations (cancer) - Mitochondrial DNA mutations - Death-resistant cells (senescence) - Extracellular matrix stiffening - Extracellular junk accumulation - Intracellular junk accumulation

How does Aubrey de Grey propose to reverse aging in *Ending Aging*?

The "Strategies for Engineered Negligible Senescence" (SENS) plan advocates repairing cellular damage rather than slowing aging. Examples include using microbial enzymes to clear intracellular junk (lysosomal aggregates) and gene therapy to delete cancer-prone mitochondrial DNA.

What is the "longevity escape velocity" concept in *Ending Aging*?

De Grey theorizes that if therapies extend lifespan by 30-40 years, future breakthroughs could repeatedly outpace aging, enabling humans to survive until truly indefinite lifespans are achievable. This hinges on iterative scientific advancements.

How has *Ending Aging* influenced anti-aging research?

The book popularized the "engineering approach" to aging, shifting focus from mere disease treatment to systemic damage repair. It spurred funding for SENS Research Foundation, though mainstream science still debates its feasibility.

What criticisms exist about *Ending Aging*?

Critics argue de Grey underestimates biological complexity and overstates near-term feasibility. Skeptics note minimal clinical progress since 2007, while others critique his dismissal of ethical concerns about lifespan inequality.

노화의 종말

우리 생애 내에 인간의 노화를 되돌릴 수 있는 회춘의 획기적 돌파구들

오브리 드 그레이 & 마이클 래

4.07(766 Reviews)

노화의 종말 개요

노화는 치료 가능한 질병일까요? 오브리 드 그레이(Aubrey de Grey)의 혁명적인 선언서는 우리가 당연하게 받아들여 온 죽음에 도전하며, 우리 생애 내에 노화를 되돌릴 수 있는 과학적 돌파구를 제안합니다. "60분(60 Minutes)"에 소개되기도 했던 이 논쟁적인 청사진은 과학자들이 인류의 가장 오래된 숙적에 접근하는 방식을 변화시켰습니다.

전달 방식을 선택하세요

한 권의 책, 다양한 듣기 방식.

노화의 종말의 같은 아이디어를 담았습니다. 나에게 맞는 목소리, 깊이, 속도를 고르고 언제든 바꿔 보세요.

1장

The Race Against Mortality: How Science Is Rewriting Our Biological Destiny

What if I told you that aging isn't inevitable? That the first person who might live to 1,000 years old has already been born? Aubrey de Grey's groundbreaking work "Ending Aging" has become a cornerstone text in the emerging field of biogerontology, garnering attention from tech billionaires like Peter Thiel and Jeff Bezos who have invested millions in longevity research. When de Grey first proposed his radical theories in the early 2000s, mainstream scientists dismissed him as fringe. Today, his SENS Research Foundation collaborates with Harvard, MIT, and Oxford. The book's central premise-that aging is simply accumulated damage we can systematically repair-has transformed how we think about human lifespan, inspiring Netflix documentaries and TED talks with millions of views. As life expectancy plateaus in developed nations, de Grey's roadmap for extending healthy human lifespan has never been more relevant.

2장

Breaking the Pro-Aging Trance: Aging as a Solvable Engineering Problem

For millennia, humans have accepted aging as an immutable fact of existence-an attitude de Grey calls the "pro-aging trance." This psychological defense mechanism helps us cope with what seems inevitable, but it's become a major obstacle to scientific progress. The distinction between "aging itself" and "age-related diseases" is artificial-a funding strategy that has backfired terribly as policy makers question why they should fund research on something "not a disease." In reality, aging is simply the collective early stages of various age-related diseases. Despite its apparent mysteriousness, aging's slow progression compared to specific diseases is simply because it's a downward spiral that accelerates over time. The similar aging rates within species and different rates between species don't indicate an immutable "aging clock"-they reflect genetic similarities and the interconnected nature of aging processes. Fundamentally, aging is a maintenance problem like that of cars or houses. Just as a vintage car can be preserved indefinitely with proper care, our bodies could theoretically be maintained through regular repair of accumulated damage. Our bodies' built-in repair systems actually make combating aging more feasible than fixing similarly complex machines. Laboratory evidence has already demonstrated life extension in various organisms. Michael Rose bred fruit flies to live twice as long through selective breeding. Calorie restriction, discovered by Clive McCay in the 1930s, extends lifespan in various species. Tom Johnson and Cynthia Kenyon discovered single-gene mutations in nematodes that extended lifespan by 50% or more. However, these approaches have limitations. Calorie restriction's effectiveness diminishes in longer-lived species, it only slows damage accumulation rather than repairing existing damage, and it has a fixed ceiling of effectiveness. We need a more comprehensive approach-one that directly addresses the fundamental forms of damage that constitute aging.

들리는 모든 단어를 눈으로 확인하세요

노화의 종말의 각 단어가 오디오에 맞춰 실시간으로 강조되어 편하게 따라 읽을 수 있습니다.

3장

The Seven Deadly Things: Identifying Aging's Root Causes

In a Manhattan Beach hotel room at 4 AM, jet-lagged and frustrated after a day of seemingly unproductive debates with leading biogerontologists, de Grey experienced his pivotal breakthrough. While wrestling with the overwhelming complexity of metabolism and aging, he realized researchers had been asking the wrong question. The key issue wasn't understanding the intricate web of metabolic processes causing aging damage, but rather identifying and addressing the damage itself. Through careful analysis, he methodically cataloged seven distinct forms of cellular and molecular damage that accumulate with age: 1. Chromosomal mutations leading to cancer, where DNA damage accumulates in the cell nucleus 2. Mitochondrial mutations caused by free radical damage, compromising cellular energy production 3. Glycation cross-linking between proteins, particularly affecting tissue elasticity in arteries and skin 4. Extracellular junk accumulation, including beta-amyloid plaques in Alzheimer's and arterial atherosclerosis 5. Intracellular waste buildup, such as lipofuscin in cells that can't be broken down 6. Cellular senescence creating harmful inflammatory signaling that damages surrounding tissue 7. Cell loss and atrophy, particularly in critical tissues like heart muscle, neurons, and stem cell populations The revelation was profound - for each category of damage, researchers were already developing potential interventions. Some examples included stem cell therapy for cell loss, senolytic drugs for removing senescent cells, and enzymes capable of breaking down accumulated waste products. This meant that complete understanding of aging's complex causes wasn't necessary to begin developing treatments. This comprehensive damage-repair approach evolved into SENS (Strategies for Engineered Negligible Senescence). Unlike traditional gerontology that focuses on unraveling complex metabolic pathways, SENS takes a practical engineering approach by targeting the accumulated damage directly. This strategy operates at the crucial intermediate stage between metabolism and pathology - intervening early enough to prevent cascading system failure but late enough to avoid disrupting essential metabolic processes. The approach mirrors modern preventive maintenance in complex machinery. Just as automotive engineers don't need to understand every aspect of metal fatigue to replace worn brake pads, medical researchers don't need complete knowledge of all aging pathways to repair specific types of cellular damage. A mechanic maintains a car's function by regularly replacing deteriorating components before they cause catastrophic failure. Similarly, SENS proposes maintaining human health by periodically repairing accumulated cellular and molecular damage before it triggers age-related diseases. This paradigm shift suggested that practical anti-aging interventions might be closer than previously thought. Rather than waiting for complete understanding of aging's complexity, researchers could focus on developing specific repair strategies for each type of damage - many of which were already in early stages of development across various fields of medical research.

4장

Mitochondrial Mutations: Powering Down Our Cellular Engines

Mitochondria, our cellular "power plants," convert food energy into ATP through a process called oxidative phosphorylation. During this process, electrons occasionally "fumble" and create superoxide radicals that damage nearby structures, particularly mitochondrial DNA, which codes for thirteen essential proteins and suffers significantly more oxidative damage than nuclear DNA. The popular "vicious cycle" theory of mitochondrial decay in aging has been thoroughly debunked. While this theory suggested that free radical damage to mitochondria would progressively worsen with age, creating a self-accelerating cycle of dysfunction, the data tells a completely different story. A puzzling finding challenged the entire mitochondrial theory of aging: only about 1% of cells in aged organisms contain mutant mitochondria, while 99% maintain perfect mitochondrial health into old age. This tiny proportion seemed insufficient to explain systemic aging. De Grey resolved this paradox with his "Survival of the Slowest" theory. Mitochondria with DNA mutations that disable oxidative phosphorylation actually produce fewer free radicals, resulting in less membrane damage. Since cells target mitochondria for destruction based on membrane damage rather than DNA integrity, these mutants escape the cellular recycling system. When the cell signals for mitochondrial replication to replace destroyed units, the mutants-with their pristine membranes but damaged DNA-reproduce while their genetically healthy counterparts get culled. But how do these rare mutant-filled cells drive aging throughout the entire body? De Grey's "Reductive Hotspot Hypothesis" explains that mitochondrially mutant cells must export electrons to survive, potentially spreading toxicity throughout the body in the process. They use the Plasma Membrane Redox System (PMRS) to export electrons, creating a "reductive hotspot" at the cell surface. These electrons likely generate superoxide radicals that damage passing LDL cholesterol particles, which then become "Trojan horses," delivering toxic, oxidized cholesterol to cells throughout the body. Rather than trying to prevent mitochondrial DNA damage, de Grey advocates for "allotopic expression"-creating backup copies of mitochondrial genes in the cell nucleus, safely away from free radical bombardment. While mutations would still occur at the same rate in mitochondria, they'd become functionally irrelevant since the cell could produce necessary proteins from the nuclear backups.

노화의 종말에서 더 많은 것을 얻으세요

매일 새로운 인사이트를 10만 개 이상의 레슨에서 만나보세요
단어가 강조되어 오디오와 실시간으로 동기화됩니다
내 라이브러리를 저장하고 모든 기기에서 이용하세요

5장

Cellular Junk Removal: Upgrading Our Biological Incinerators

Just as households generate garbage that requires regular disposal, our cells continuously produce waste during their normal functioning. Lysosomes, often called the cell's recycling centers, are specialized membrane-bounded organelles filled with over 60 different types of digestive enzymes. These enzymes function like molecular demolition crews, each targeting specific chemical structures through hydrolysis - a process that physically tears apart molecular joints like microscopic crowbars. This precise targeting ensures efficient breakdown of everything from worn-out organelles to misfolded proteins. As we age, our cells face a growing challenge: the accumulation of certain waste products that our lysosomes cannot break down effectively. A prime example is lipofuscin, often called "aging pigment," which consists of cross-linked proteins and lipids with distinctive fluorescent properties. These materials become increasingly resistant to degradation over time. Brunk and Terman's "garbage catastrophe" theory explains how this accumulation creates a vicious cycle: as undegraded waste builds up, it dilutes lysosomal acidity and enzymes, making them less effective at their normal digestive functions. This impairment leads to even more accumulation, creating a downward spiral of cellular dysfunction. Lysosomal failure plays a central role in numerous age-related diseases. In atherosclerosis, for instance, specialized immune cells called macrophages attempt to clean up modified low-density lipoproteins (LDL) from blood vessel walls. When these macrophages become overwhelmed by oxidized or glycated LDL, their lysosomes fail, transforming them into "foam cells" that accumulate in vessel walls. These foam cells eventually form unstable atherosclerotic plaques that can rupture, potentially causing heart attacks or strokes. Similarly, major neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's all show evidence of compromised lysosomal function, with toxic protein aggregates accumulating in brain cells. De Grey's innovative solution, termed LysoSENS, draws inspiration from nature's own cleanup crew: soil bacteria that decompose organic matter after death. His approach involves identifying these bacterial species, isolating their specialized enzymes, and developing methods to deliver these enzymes into human lysosomes. His team's groundbreaking work began by collecting soil samples from an ancient mass grave, where they successfully isolated microorganisms capable of using synthetic lipofuscin as their sole nutrient source. This discovery validated their hypothesis that nature had already evolved solutions to break down these supposedly "undegradable" compounds. The practical implementation of LysoSENS benefits from existing biotechnology developed for treating lysosomal storage diseases (LSDs). Enzyme replacement therapy (ERT) has already proven successful in treating several LSDs, including Gaucher's disease, Fabry disease, and Pompe disease. For example, approximately four thousand Gaucher's disease patients now lead normal lives through regular enzyme infusions. These established therapeutic approaches provide a clear pathway for delivering new waste-degrading enzymes to human lysosomes, potentially revolutionizing the treatment of age-related diseases.

6장

Immunotherapy Against Amyloid: Cutting Free of Cellular Spider Webs

Our cells accumulate protein-derived junk in the spaces between them as we age. While Alzheimer's disease is the most recognized condition associated with this extracellular debris, many other fatal conditions result from similar mechanisms. Beta-amyloid causes damage beyond Alzheimer's disease. It also accumulates in blood vessels, causing cerebral amyloid angiopathy (CAA), which weakens vessel walls and leads to bleeding strokes. Senile cardiac amyloidosis, caused by misfolded transthyretin, interferes with heart function and affects about 25% of people over ninety. Rather than breaking apart beta-amyloid plaques, de Grey favors removing them entirely through immunotherapy. Researchers discovered that microglial cells-the brain's immune cells-naturally consume beta-amyloid deposits, though too slowly to keep pace with deposition in Alzheimer's patients. Scientists hypothesized this natural defense could be stimulated through vaccination. Initial animal testing of the beta-amyloid vaccine showed remarkable results. In engineered mice with Alzheimer's-like symptoms, plaques regressed, neurite swelling decreased, inflammatory cell overgrowth retreated, and memory function improved significantly. Though human trials were halted due to side effects, autopsies of deceased vaccine responders revealed dramatically reduced plaque levels compared to controls. These findings have revitalized beta-amyloid vaccination as a potential Alzheimer's cure. Scientists have developed new approaches to retain efficacy while eliminating dangerous side effects, including passive vaccination, which directly provides carefully selected antibodies, and vaccines using only specific parts of the beta-amyloid molecule. The same immunological strategies being developed for Alzheimer's can likely be applied to other age-related amyloid disorders. The 11-1F4 antibody developed for AL amyloidosis also effectively treats other amyloid disorders, reducing organ amyloid burden by over 75% in both liver and spleen. This cross-reactivity suggests different amyloids share similar molecular architecture.

들리는 모든 단어를 눈으로 확인하세요

노화의 종말의 각 단어가 오디오에 맞춰 실시간으로 강조되어 편하게 따라 읽을 수 있습니다.

7장

Breaking AGE Crosslinks: Restoring Tissue Flexibility

Year after year, chemical processes shackle our body's structural proteins together, preventing them from performing their vital functions. Through the same chemical processes that brown or caramelize food, sugars attach to and warp proteins in our bodies. These reactions progress through several stages-from unstable Schiff bases to more stable Amadori products and finally to permanent AGE cross-links that shackle neighboring proteins together. AGE cross-links devastate our bodies by stiffening tissues everywhere. In the cardiovascular system, they harden arteries, increasing blood pressure and making vessels brittle. They impair the heart's ability to contract and expand properly, eventually leading to heart failure. In the eyes, AGEs accumulate on crystallin proteins, creating the brown spots we know as cataracts. Peter Ulrich and his team at Alteon discovered compounds that could break existing AGE cross-links rather than merely preventing new ones. Their compound ALT-711 (alagebrium) showed remarkable results in animal studies. In older dogs, just one month of treatment made hearts 42 percent more flexible. In aging rhesus monkeys, alagebrium increased arterial flexibility by up to 60 percent and improved heart filling capacity by 16 percent. Unfortunately, subsequent trials involving over a thousand patients with various conditions revealed that while alagebrium appears safe and does break AGEs, its effects on actual function are insufficient for clinical impact. This paradox suggests that alpha-diketone cross-links may be proportionally less important in longer-lived humans than in shorter-lived laboratory animals. While alagebrium won't play a major role in reversing cross-link damage in humans, it serves as crucial proof-of-principle that AGEs can be cleaved and tissues regenerated. The future requires developing a new generation of AGE-breakers targeting more abundant cross-links. No single drug will eliminate all cross-linking-we'll need multiple compounds targeting different AGE structures.

8장

Eliminating Harmful Cells: Putting the Zombies to Rest

As we age, we accumulate "death-resistant" cells in our tissues-part of our biochemical defense against cancer. Rather than remaining harmless, these senescent cells damage surrounding tissue through inappropriate chemical signals. The immune system's decline is one of aging's deadliest effects. Infections like influenza that young people easily overcome kill approximately 51,000 Americans annually, with over 90 percent of deaths occurring in people over sixty-five. The problem with persistent T cells isn't just their refusal to retire-they become dysfunctional (anergic) while occupying valuable immune system space. These cells lose their CD28 surface receptor, preventing antigen-presenting cells from alerting them to threats. They also express both KLRG1 and CD57 markers, locking down their ability to reproduce even when facing active threats. The consequences of immune senescence extend far beyond increased susceptibility to infection. When elderly people contract influenza, they suffer shocking long-term consequences including increased risk of heart attacks, strokes, and unrelated respiratory disorders. Rather than rehabilitation, the solution is elimination-removing anergic T-cell clones to free up immunological space for healthy cells. Targeted cancer therapies like Gleevec, Iressa, and Herceptin offer a model for eliminating anergic T cells. By reverse-engineering these approaches, we could couple carefully chosen toxins to molecules that selectively target the signatures of anergic T-cell clones. Visceral fat surrounding internal organs (unlike subcutaneous fat under the skin) causes age-related insulin resistance and inflammation. As fat depots grow, adipocytes pump out more inflammatory signals, creating a self-reinforcing feedback loop with infiltrating macrophages that directly causes insulin resistance. Senescent cells, though rare even in aged people, actively harm surrounding tissues. Beyond losing their ability to divide, they desperately try to stimulate activity by pumping out harmful substances. These zombie cells must be eliminated, not rehabilitated, as reversing senescence risks unleashing cancer from cells that became senescent precisely to prevent malignancy.

노화의 종말에서 더 많은 것을 얻으세요

매일 새로운 인사이트를 10만 개 이상의 레슨에서 만나보세요
단어가 강조되어 오디오와 실시간으로 동기화됩니다
내 라이브러리를 저장하고 모든 기기에서 이용하세요

9장

Stem Cell Therapies and Cancer Prevention: The Final Frontiers

Throughout life, we gradually lose cells vital to our health through various mechanisms including oxidative stress, environmental damage, and programmed cell death. Many fatal age-related diseases, like Parkinson's, Alzheimer's, and heart disease, result from losing specific cell populations crucial to bodily function. Stem cell therapies represent a revolutionary approach to replacing these missing cells and potentially reversing age-related decline. Embryonic stem cells (ESCs) are primordial "master cells" with remarkable plasticity. With proper biochemical stimulation, ESCs can differentiate into any cell type in the body-nerve, muscle, heart, kidney, liver, pancreas, and more-making them essential for repairing tissues lost to age-related diseases. This pluripotency is regulated by complex genetic networks and environmental factors that scientists are increasingly able to control and direct. Beyond cardiac repair, embryonic stem cells have demonstrated remarkable therapeutic potential in animal models of numerous devastating conditions. Studies have shown successful treatment of juvenile diabetes through insulin-producing beta cell replacement, spinal cord injuries via neural cell regeneration, multiple sclerosis through immune system modulation, cerebral palsy, stroke recovery through neural tissue repair, Parkinson's disease via dopamine neuron replacement, ALS-like paralysis, and macular degeneration through retinal cell restoration. Each success brings us closer to human applications. Nuclear DNA faces constant assault, suffering accumulating damage over time-approximately a million damaging "hits" per cell every day. These come from multiple sources: ionizing radiation, UV light, environmental toxins, and metabolic by-products like free radicals. While most nuclear mutations have negligible effects on overall bodily function due to repair mechanisms and redundancy, cancer represents the critical exception. Cancer's age-related incidence increases exponentially because it can arise from mutations in numerous different genes related to cell cycle control, programmed cell death (apoptosis), growth signaling pathways, or telomerase activation. Each mutation brings cells closer to malignant transformation. De Grey's proposed solution is WILT (Whole-body Interdiction of Lengthening of Telomeres)-a radical approach involving completely deleting the telomerase gene from every cell in the body. Without telomere renewal capability, potential cancer cells would rapidly reach their replication limit and undergo senescence, resulting in harmless, short-lived lumps rather than malignant disease. This approach would theoretically prevent virtually all cancers, regardless of their molecular origins. To address the inevitable side effects of telomerase elimination, particularly in rapidly dividing tissues, de Grey proposes periodically replenishing stem cell pools with new cells engineered to have long telomeres but lacking telomerase genes. Based on observed human blood stem cell division rates and telomere shortening dynamics, we should be able to go about a decade between bone marrow replacements. Similar approaches would be needed for other tissues with high turnover rates, such as skin and intestinal lining. This combined strategy of stem cell therapy and cancer prevention through telomere control represents a comprehensive approach to addressing two major challenges of aging: tissue degeneration and cancer susceptibility. While technically challenging, these interventions could dramatically extend healthy human lifespan.

10장

Longevity Escape Velocity: The Path to 1,000-Year Lifespans

The therapies we'll develop won't be perfect at first. Even with regular treatment, some cellular and molecular damage will still accumulate, eventually causing age-related decline and death. However, these initial treatments are expected to extend life by 30-50 years beyond current lifespans while maintaining good health. This additional time is crucial, as it creates opportunities for subsequent therapeutic advances. De Grey maintains that many people alive today will live to 1,000 years while remaining healthy, not through a single breakthrough, but through successive waves of increasingly sophisticated treatments. The concept of "longevity escape velocity" (LEV) represents a threshold rate of biomedical progress that would allow us to stave off aging indefinitely. The mathematics are compelling: if we develop robust human rejuvenation by 2031 that doubles a sixty-year-old's remaining lifespan, we'll have twenty years to improve those therapies before they need another treatment. During this period, scientific understanding and technological capabilities will advance significantly, enabling the development of more effective interventions. This creates a virtuous cycle where each treatment buys enough time to develop better treatments, effectively outrunning the aging process. Historical patterns of technological advancement support this theory. Fundamental breakthroughs in any field are notoriously difficult to predict and achieve, but once accomplished, incremental improvements proceed at a steady, reliable pace. Aviation provides a perfect illustration: after centuries of failed attempts, the Wright brothers achieved powered flight in 1903. The subsequent progress was remarkable and predictable - Lindbergh crossed the Atlantic in 1927, commercial jetliners became widespread in the 1950s, and supersonic passenger flight began in the 1970s. Each advancement built upon previous successes in a systematic way. Medical technologies follow similar patterns - consider how organ transplantation, once revolutionary, has become routine and increasingly sophisticated. De Grey and his colleagues have performed detailed calculations suggesting that achieving LEV would require approximately doubling the efficacy of SENS (Strategies for Engineered Negligible Senescence) therapies every forty years. This pace of improvement appears feasible given historical rates of medical advancement and the accelerating pace of biotechnology research. While complete mastery over the aging process might take centuries to achieve, the interim goal is more modest and achievable: giving middle-aged people an additional thirty years of youthful life. This "bridge" strategy would keep people alive and healthy long enough to benefit from subsequent advances. The implications of reaching LEV extend beyond individual longevity. Each therapeutic advancement would likely improve not just lifespan but also healthspan - the period of life spent in good health. The compounding nature of these improvements means that early successes in rejuvenation therapy could create a cascade effect, leading to increasingly effective treatments that eventually amount to a practical fountain of youth, accessible through periodic medical interventions rather than a single magical solution.

★★★★★

노화의 종말 완독을 축하합니다

100만 명 이상의 학습자가 사랑합니다

“23일째 매일 사용하고 있어요. 이제 제 일상의 한 부분이 되었습니다.”

jayallen

노화의 종말의 핵심 주제

biological damage repair
strategies for engineered negligible senescence
radical life extension
biogerontology engineering
cellular waste accumulation

노화의 종말의 명언

Aging isn't inevitable.
Aging is simply accumulated damage we can systematically repair.
Aging is simply the collective early stages of various age-related diseases.
Aging is a maintenance problem like that of cars or houses.
Researchers had been asking the wrong question.

노화의 종말의 등장인물

Aubrey de GreyLead author and biomedical gerontologist
Michael RaeCo-author and longevity researcher
Michael RoseScientist who bred long-lived fruit flies
Cynthia KenyonResearcher who discovered lifespan-extending genes
Clive McCayScientist who discovered calorie restriction

저자 소개

선구적인 생물의학 노년학자인 오브리 드 그레이(Aubrey de Grey)와 과학 저술가이자 장수 연구가인 마이클 레이(Michael Rae)는 *노화의 종말: 우리 세대에 인간의 노화를 되돌릴 수 있는 회춘의 돌파구(Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime)*를 공동 집필했습니다.

1963년 영국에서 태어난 드 그레이는 노화로 인한 쇠퇴에 맞서는 재생 치료법을 개략적으로 설명하는 "공학적 무시해도 될 정도의 노화 전략"(Strategies for Engineered Negligible Senescence, SENS) 프레임워크를 개발한 것으로 유명합니다. 그의 이전 저서인 *노화의 미토콘드리아 자유 라디칼 이론(The Mitochondrial Free Radical Theory of Aging)*은 항노화 연구 분야에서 그의 명성을 확립했습니다. SENS 연구 재단의 오랜 기여자인 레이는 칼로리 제한 과학과 노화 생물학 분야의 전문 지식을 제공합니다.

트랜스휴머니즘 문헌의 초석인 이 책은 드 그레이의 선견지명 있는 생물의학 전략과 레이의 과학적 커뮤니케이션 기술을 결합했습니다. 수백만 회의 조회수를 기록한 드 그레이의 2006년 노화 역전에 관한 TED 강연과 모스크바 물리 기술 대학의 겸임 교수직을 포함한 그의 학술적 역할은 그의 권위를 뒷받침합니다.

2007년 세인트 마틴 프레스(St. Martin’s Press)에서 출간된 노화의 종말은 노화를 해결 가능한 공학적 과제로 옹호하는 영향력 있는 텍스트로 남아 있습니다.

노화의 종말 요약 다운로드

노화의 종말 요약을 무료 PDF 또는 EPUB으로 받으세요. 인쇄하거나 오프라인에서 언제든 읽을 수 있습니다.

다른 사용자들도 좋아한 책

Ageless

Andrew Steele

Science-Backed Secrets to Reverse Biological Aging 책 표지

Lifestyle interventions to delay senescence

6 sources

Science-Backed Secrets to Reverse Biological Aging

Lifespan

Dr David A. Sinclair

Science and Technology of Growing Young, Updated Edition

Sergey Young

Super Human

Dave Asprey

The Biology of Aging and the Quest for Immortality 책 표지

The art of dying slowly: Review of Venki Ramakrishnan’s ‘Why We Die’ - The Hindu

Venki Ramakrishnan’s “Why We Die” Offers a Clear-eyed Look at Ageing, and the Limits of Longevity - Frontline

Why We Die by Venki Ramakrishnan | Summary, Quotes, FAQ, Audio

Why do we die? Can ageing be reversed? Here is what Nobel laureate Venki Ramakrishnan says- The Week

4 sources

The Biology of Aging and the Quest for Immortality

Outlive

Peter Attia

The Biology of Aging: Reversing the Clock in Your Cells 책 표지

Lifespan: Why We Age—and Why We Don’t Have To

Ageless: The New Science of Getting Older Without Getting Old

26 sources

The Biology of Aging: Reversing the Clock in Your Cells

BeFreed

이 책에 대한 FAQ

이 학습 계획의 일부

학습 계획

Learning about Nanobiotechnology

5 h 34 m•4 에피소드

더 알아보기

학습 계획

AI Strategies for Radical Longevity

This plan is essential for researchers and tech innovators aiming to merge biotechnology with artificial intelligence. It provides the framework needed to transform aging from an inevitability into a manageable biological process through data-driven engineering.

1 h 12 m•3 섹션

학습 계획

The Medicine 3.0 Longevity Blueprint

This blueprint is designed for individuals looking to move beyond traditional medicine and take control of their aging process. It is ideal for high-performers and health-conscious learners who want to build a science-backed foundation for lifelong vitality and physical independence.

1 h 45 m•4 섹션

학습 계획

The Art of Aging Gracefully

This plan is designed for individuals seeking to redefine their relationship with time by focusing on holistic well-being and character depth. It is ideal for those who want to trade the pursuit of youth for a life of vitality, emotional steadiness, and profound social connection.

1 h 36 m•4 섹션

학습 계획

Health and longevity

This learning plan is essential for anyone seeking to optimize their health trajectory and add quality years to their life through science-backed strategies. It's ideal for health-conscious individuals, healthcare professionals, and biohackers who want to move beyond generic wellness advice to understand and apply the latest longevity science. Whether you're looking to prevent age-related decline or maximize your current vitality, this comprehensive approach bridges timeless wisdom with cutting-edge research.

4 h 21 m•4 섹션

학습 계획

The Longevity Toolkit

Modern medicine often focuses on treating symptoms rather than preventing root causes. This toolkit is essential for health-conscious individuals and high-performers who want to master their metabolism and skeletal health for a longer, more vibrant life.

1 h 12 m•3 섹션

학습 계획

Clinical Longevity and Functional Protocols

This learning plan is essential for healthcare practitioners looking to bridge the gap between reactive treatment and proactive geroscience. It provides the clinical framework needed to measure and manage the aging process using advanced diagnostics and functional protocols.

1 h 30 m•3 섹션

학습 계획

The Medicine 3.0 Performance Manual

This manual is essential for high-performers and health-conscious individuals seeking to move beyond traditional healthcare. It provides a data-driven framework for extending lifespan through metabolic optimization and advanced preventative screening.

3 h•4 섹션

학습 계획

The Metabolic Shift: Navigating Your 30s

As biological systems shift in your 30s, standard fitness advice often fails to address underlying hormonal and cellular changes. This plan is designed for professionals and proactive individuals looking to master their metabolic health through science-backed strategies.

2 h•4 섹션

샌프란시스코에서 컬럼비아 대학교 동문들이 만들었습니다

LOVED BY

1,000,000+ curious minds.

4.7

avg rating

1M+ learners

"Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."

@Moemenn

"I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."

@Chloe, Solo founder, LA

117

"Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."

@Raaaaaachelw

"Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."

@Matt, YC alum

108

"Reading used to feel like a chore. Now it’s just part of my lifestyle."

@Erin, Investment Banking Associate , NYC

254

"Feels effortless compared to reading. I’ve finished 6 books this month already."

@djmikemoore

"BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."

@Pitiful

4.5K

"BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."

@SofiaP

"BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"

@Jaded_Falcon

201

"It is great for me to learn something from the book without reading it."

@OojasSalunke

"The themed book list podcasts help me connect ideas across authors—like a guided audio journey."

@Leo, Law Student, UPenn

483

"Makes me feel smarter every time before going to work"

@Cashflowbubu

웹에서 BeFreed가 어떻게 논의되고 있는지 더 보기

샌프란시스코에서 컬럼비아 대학교 동문들이 만들었습니다

LOVED BY

1,000,000+ curious minds.

4.7

avg rating

1M+ learners

"Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."

@Moemenn

"I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."

@Chloe, Solo founder, LA

117

"Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."

@Raaaaaachelw

"Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."

@Matt, YC alum

108

"Reading used to feel like a chore. Now it’s just part of my lifestyle."

@Erin, Investment Banking Associate , NYC

254

"Feels effortless compared to reading. I’ve finished 6 books this month already."

@djmikemoore

"BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."

@Pitiful

4.5K

"BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."

@SofiaP

"BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"

@Jaded_Falcon

201

"It is great for me to learn something from the book without reading it."

@OojasSalunke

"The themed book list podcasts help me connect ideas across authors—like a guided audio journey."

@Leo, Law Student, UPenn

483

"Makes me feel smarter every time before going to work"

@Cashflowbubu

"Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."

@Moemenn

"I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."

@Chloe, Solo founder, LA

117

"Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."

@Raaaaaachelw

"Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."

@Matt, YC alum

108

"Reading used to feel like a chore. Now it’s just part of my lifestyle."

@Erin, Investment Banking Associate , NYC

254

"Feels effortless compared to reading. I’ve finished 6 books this month already."

@djmikemoore

"BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."

@Pitiful

4.5K

"BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."

@SofiaP

"BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"

@Jaded_Falcon

201

"It is great for me to learn something from the book without reading it."

@OojasSalunke

"The themed book list podcasts help me connect ideas across authors—like a guided audio journey."

@Leo, Law Student, UPenn

483

"Makes me feel smarter every time before going to work"

@Cashflowbubu

"Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."

@Moemenn

"I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."

@Chloe, Solo founder, LA

117

"Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."

@Raaaaaachelw

"Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."

@Matt, YC alum

108

"Reading used to feel like a chore. Now it’s just part of my lifestyle."

@Erin, Investment Banking Associate , NYC

254

"Feels effortless compared to reading. I’ve finished 6 books this month already."

@djmikemoore

"BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."

@Pitiful

4.5K

"BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."

@SofiaP

"BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"

@Jaded_Falcon

201

"It is great for me to learn something from the book without reading it."

@OojasSalunke

"The themed book list podcasts help me connect ideas across authors—like a guided audio journey."

@Leo, Law Student, UPenn

483

"Makes me feel smarter every time before going to work"

@Cashflowbubu

웹에서 BeFreed가 어떻게 논의되고 있는지 더 보기

지금 바로 학습 여정을 시작하세요

9장

노화의 종말

개요노화의 종말 개요

한 권의 책, 다양한 듣기 방식.

The Race Against Mortality: How Science Is Rewriting Our Biological Destiny

Breaking the Pro-Aging Trance: Aging as a Solvable Engineering Problem

들리는 모든 단어를 눈으로 확인하세요

The Seven Deadly Things: Identifying Aging's Root Causes

Mitochondrial Mutations: Powering Down Our Cellular Engines

노화의 종말에서 더 많은 것을 얻으세요

Cellular Junk Removal: Upgrading Our Biological Incinerators

Immunotherapy Against Amyloid: Cutting Free of Cellular Spider Webs

들리는 모든 단어를 눈으로 확인하세요

Breaking AGE Crosslinks: Restoring Tissue Flexibility

Eliminating Harmful Cells: Putting the Zombies to Rest

노화의 종말에서 더 많은 것을 얻으세요

Stem Cell Therapies and Cancer Prevention: The Final Frontiers

Longevity Escape Velocity: The Path to 1,000-Year Lifespans

노화의 종말 완독을 축하합니다

노화의 종말의 핵심 주제

노화의 종말의 명언

노화의 종말의 등장인물

저자 소개

노화의 종말 요약 다운로드

다른 사용자들도 좋아한 책

이 책에 대한 FAQ

What is Ending Aging by Aubrey de Grey about?

Who should read Ending Aging?

Is Ending Aging worth reading?

What are the seven types of aging damage identified in Ending Aging?

이 학습 계획의 일부

Learning about Nanobiotechnology

더 알아보기

1,000,000+ curious minds.

1,000,000+ curious minds.

한 권의 책, 다양한 듣기 방식.

The Race Against Mortality: How Science Is Rewriting Our Biological Destiny

Breaking the Pro-Aging Trance: Aging as a Solvable Engineering Problem

들리는 모든 단어를 눈으로 확인하세요

The Seven Deadly Things: Identifying Aging's Root Causes

Mitochondrial Mutations: Powering Down Our Cellular Engines

노화의 종말에서 더 많은 것을 얻으세요

Cellular Junk Removal: Upgrading Our Biological Incinerators

Immunotherapy Against Amyloid: Cutting Free of Cellular Spider Webs

들리는 모든 단어를 눈으로 확인하세요

Breaking AGE Crosslinks: Restoring Tissue Flexibility

Eliminating Harmful Cells: Putting the Zombies to Rest

노화의 종말에서 더 많은 것을 얻으세요

Stem Cell Therapies and Cancer Prevention: The Final Frontiers

Longevity Escape Velocity: The Path to 1,000-Year Lifespans

노화의 종말 완독을 축하합니다

다른 사용자들도 좋아한 책

이 학습 계획의 일부

Learning about Nanobiotechnology

더 알아보기

노화의 종말 개요